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Endocannabinoids are key modulators of synaptic function. By activating cannabinoid receptors expressed
in the central nervous system, these lipidmessengers can regulate several neural functions and behaviors. As
experimental tools advance, the repertoire of known endocannabinoid-mediated effects at the synapse, and
their underlying mechanism, continues to expand. Retrograde signaling is the principal mode by which
endocannabinoids mediate short- and long-term forms of plasticity at both excitatory and inhibitory
synapses. However, growing evidence suggests that endocannabinoids can also signal in a nonretrograde
manner. In addition to mediating synaptic plasticity, the endocannabinoid system is itself subject to plastic
changes. Multiple points of interaction with other neuromodulatory and signaling systems have now been
identified. In this Review, we focus on new advances in synaptic endocannabinoid signaling in the mamma-
lian brain. The emerging picture not only reinforces endocannabinoids as potent regulators of synaptic
function but also reveals that endocannabinoid signaling is mechanistically more complex and diverse
than originally thought.Introduction
Since the discovery of D9-tetrahydrocannabinol (THC) as the
main psychoactive ingredient in marijuana, and the cloning of
cannabinoid receptors and the identification of their endogenous
ligands (endocannabinoids [eCBs]), our understanding of the
molecular basis and functions of the eCB signaling system has
evolved considerably. Extensive research in the last 15 years
has consolidated our view on eCBs as powerful regulators of
synaptic function throughout the CNS. Their role as retrograde
messengers suppressing transmitter release in a transient or
long-lasting manner, at both excitatory and inhibitory synapses,
is now well established (Alger, 2012; Chevaleyre et al., 2006;
Freund et al., 2003; Kano et al., 2009; Katona and Freund,
2012). Apart from signaling in more mature systems, the eCB
system has been implicated in synapse formation and neurogen-
esis (Harkany et al., 2008). It is alsowidely believed that bymodu-
lating synaptic strength, eCBscan regulate awide rangeof neural
functions, including cognition, motor control, feeding behaviors,
and pain. Moreover, dysregulation of the eCB system is impli-
cated in neuropsychiatric conditions such as depression and
anxiety (Hillard et al., 2012; Mechoulam and Parker, 2012). As
such, the eCB system provides an excellent opportunity for ther-
apeutic interventions (Ligresti et al., 2009; Piomelli, 2005). Their
prevalence throughout the brain suggests that eCBs are funda-
mental modulators of synaptic function. This Review focuses
on recent advances in eCB signaling at central synapses.
The eCB signaling system comprises (1) at least twoGprotein-
coupled receptors (GPCRs), known as the cannabinoid type 1
and type 2 receptors (CB1R and CB2R); (2) the endogenous
ligands (eCBs), of which anandamide (AEA) and 2-arachidonoyl-
glycerol (2-AG) are the best characterized; and (3) synthetic and
degradative enzymes and transporters that regulate eCB levels
and action at receptors. An enormous amount of information
on the general properties of the eCB system has accumulated
over the last two decades (for general reviews on the eCB70 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.system, see Ahn et al., 2008; Di Marzo, 2009; Howlett et al.,
2002; Pertwee et al., 2010; Piomelli, 2003). We discuss essential
features of this system in the context of synaptic function.
The principal mechanism by which eCBs regulate synaptic
function is through retrograde signaling (for a thorough review,
see Kano et al., 2009). Here, postsynaptic activity leads to the
production of an eCB that moves backward across the synapse,
binds presynaptic CB1Rs, and suppresses neurotransmitter
release (Figure 1A). However, there is also evidence suggesting
that eCBs signal in a nonretrograde or autocrine manner, in
which they can modulate neural function and synaptic transmis-
sion by engaging transient receptor potential vanilloid receptor
type 1 (TRPV1) and also CB1Rs located on or within the postsyn-
aptic cell (Figure 1B). Finally, recent studies indicate that eCBs
can signal via astrocytes to indirectly modulate presynaptic or
postsynaptic function (Figure 1C). This Review aims to highlight
the emerging mechanistic diversity of synaptic eCB signaling.
Retrograde Endocannabinoid Signaling
The first demonstration of retrograde eCB signaling came from
the discovery that eCBs mediate forms of short-term synaptic
plasticity known as depolarization-induced suppression of inhi-
bition (DSI) (Ohno-Shosaku et al., 2001; Wilson and Nicoll,
2001) and depolarization-induced suppression of excitation
(DSE) (Kreitzer and Regehr, 2001). Shortly after it was shown
that eCBs also mediate presynaptic forms of long-term depres-
sion (eCB-LTD) at both excitatory (Gerdeman et al., 2002; Robbe
et al., 2002) and inhibitory (Chevaleyre and Castillo, 2003; Marsi-
cano et al., 2002) synapses. eCBs have since emerged as the
best characterized retrograde messengers (Regehr et al.,
2009), with numerous examples of short- and long-term forms
of synaptic plasticity reported throughout the brain (Heifets
and Castillo, 2009; Kano et al., 2009).
CB1/CB2 receptors are Gi/o protein-coupled receptors that
mediate almost all effects of exogenous and endogenous
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Figure 1. Endocannabinoid Signaling at the
Synapse
(A) Retrograde endocannabinoid (eCB) signaling.
eCBs are mobilized from postsynaptic neurons
and target presynaptic cannabinoid type 1
receptors (CB1Rs) to suppress neurotransmitter
release.
(B) Nonretrograde eCB signaling. eCBs produced
in postsynaptic neurons activate postsynaptic
CB1Rs or transient receptor potential vanilloid type
1 (TRPV1) channels.
(C)Neuron-astrocyteeCBsignaling. eCBs released
from postsynaptic neurons stimulate astrocytic
CB1Rs, thereby triggering gliotransmission. Glu,
glutamate.
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GPCRs in the brain (Herkenham et al., 1990). Their localization
to neuronal terminals (Katona et al., 1999, 2006) strongly
suggests that CB1Rs play important roles in regulating synaptic
function. Indeed, CB1R activation inhibits neurotransmitter
release at synapses through two main mechanisms (Figure 2)
(Chevaleyre et al., 2006; Freund et al., 2003; Kano et al., 2009).
For short-term plasticity, in which CB1Rs are activated for
a few seconds, the mechanism involves direct G protein-depen-
dent (likely via the bg subunits) inhibition of presynaptic Ca2+
influx through voltage-gated Ca2+ channels (VGCCs) (Brown
et al., 2003; Kreitzer and Regehr, 2001; Wilson et al., 2001).
For long-term plasticity, the predominant mechanism requires
inhibition of adenylyl cyclase and downregulation of the cAMP/
PKA pathway via the ai/o limb (Chevaleyre et al., 2006; Heifets
and Castillo, 2009). Moreover, CB1Rs only need to be engaged
during the induction, but not expression, phase of eCB-LTD.
Induction also requires combined presynaptic firing with CB1R
activation, thereby providing a mechanism for input specificity;
that is, only active synapses detecting eCBs express long-term
plasticity (Heifets et al., 2008; Singla et al., 2007). The expression
mechanism for eCB-LTD may involve presynaptic proteins
Rab3B/RIM1a (Chevaleyre et al., 2007; Tsetsenis et al., 2011)
or a reduction of P/Q-type VGCCs (Mato et al., 2008).While other
effectors downstream of CB1Rs have been described, mainly in
cultured cells and expression systems (Howlett, 2005; Pertwee
et al., 2010), their role in regulating synaptic function is presently
less clear. In contrast to CB1Rs, which are widely expressed in
the brain, CB2Rs are typically found in the immune system and
are poorly expressed in the CNS. Although recent studies
support a role for these receptors in the CNS (den Boon et al.,
2012; Van Sickle et al., 2005; Xi et al., 2011), when compared
with CB1Rs,much less is known about the precise cellular mech-
anism(s) and contributions of CB2Rs to brain function.
Although several eCBs have been identified, just two, AEA and
2-AG, emerged as the most relevant and prevalent regulators of
synaptic function. While 2-AG seems to be the principal eCB
required for activity-dependent retrograde signaling, the relative
contribution of 2-AG and AEA to synaptic transmission is still
debated. Functional crosstalk between 2-AG and AEA signaling
was reported (Maccarrone et al., 2008), and recent findings
suggest that 2-AG and AEA can be recruited differentially fromthe same postsynaptic neuron, depending on the type of presyn-
aptic activity (Lerner and Kreitzer, 2012; Puente et al., 2011). A
more complete signaling profile for 2-AG and AEA—including
production, target identification, and degradation—is indispens-
able for better understanding their short- and long-term impact
on synaptic function.
Synthesis and degradation of eCBs help shape their
spatiotemporal signaling profile. For retrograde eCB signaling,
postsynaptic neuronal depolarization elevates intracellular
Ca2+ via VGCCs and elicits 2-AG production presumably by acti-
vating Ca2+-sensitive enzymes. In addition, glutamate release
onto postsynaptic group I metabotropic glutamate receptors
(I mGluRs) (Maejima et al., 2001; Varma et al., 2001) can generate
2-AG by activating the enzyme phospholipase Cb (PLCb) (for a
review, see Hashimotodani et al., 2007a). Most likely, Ca2+ influx
through VGCCs and downstream signaling from I mGluR activa-
tion converge on the same metabolic pathway to mobilize 2-AG
(Figure 2A). PLCb is thought to act as a coincidence detector for
postsynaptic Ca2+ and GPCR signaling (Hashimotodani et al.,
2005; Maejima et al., 2005). This interaction might be important
for integrating synaptic activity (Brenowitz and Regehr, 2005).
On the other hand, it is worth noting that activation of I mGluRs
is sufficient to mobilize eCBs to trigger short- and long-term
forms of plasticity (Chevaleyre et al., 2006). For long-term plas-
ticity, a few minutes of CB1R stimulation is needed, which can
result from a brief postsynaptic I mGluR activation triggering
a relatively longer-lasting 2-AG mobilization (Chevaleyre and
Castillo, 2003). Of general physiological relevance, many other
Gq/11-GPCRs are known to promote eCB synthesis (Katona
and Freund, 2012). Upon activation, PLCb hydrolyzes phospha-
tidylinositol to generate diacylglycerol, which is converted to
2-AG by diacylglycerol lipase a (DGLa). DGLa is specifically
localized to postsynaptic compartments (Katona et al., 2006;
Lafourcade et al., 2007; Nomura et al., 2007; Yoshida et al.,
2006). Whereas pharmacological studies inconsistently impli-
cated DGLa in short-term synaptic plasticity, genetic deletion
of DGLa indicates that this enzyme is required for Ca2+-depen-
dent 2-AG production and short- and long-term eCB-dependent
synaptic plasticity (Gao et al., 2010; Tanimura et al., 2010;
Yoshino et al., 2011). Once synthesized, 2-AG travels backward
across the synapse; however, the precise mechanism by which
this occurs is still unresolved.Neuron 76, October 4, 2012 ª2012 Elsevier Inc. 71
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Figure 2. Molecular Mechanisms
Underlying Endocannabinoid-Mediated
Short- and Long-Term Synaptic Plasticity
(A) Short-term depression. Postsynaptic activity
triggers Ca2+ influx via voltage-gated Ca2+ chan-
nels (VGCCs). Other Ca2+ sources, like NMDARs
and internal stores, may contribute. Ca2+ pro-
motes diacylglycerol lipase (DGLa)-mediated eCB
production by an unknown mechanism. Presyn-
aptic activity can also lead to eCB mobilization by
activating postsynaptic group I metabotropic
glutamate receptors (I mGluRs). Phospholipase-
Cb (PLCb) can now act as a coincidence detector
integrating pre- and postsynaptic activity. DGLa
promotes 2-arachidonoylglycerol (2-AG) release,
which retrogradely targets presynaptic CB1Rs,
and the bg subunits probably couple to presyn-
aptic VGCCs to reduce neurotransmitter release.
(B) eCB-mediated excitatory long-term depres-
sion (LTD) and inhibitory LTD (iLTD). Patterned
presynaptic stimulation releases glutamate (Glu),
which activates postsynaptic mGluRs coupled
to PLCb and DGLa. 2-AG homosynaptically
targets CB1Rs localized to excitatory terminals
and heterosynaptically engages CB1Rs at inhibi-
tory terminals. A Gai/o-dependent reduction in adenylyl cyclase (AC) and protein kinase A (PKA) activity suppresses transmitter release. At inhibitory synapses,
decreased PKA activity, in conjunction with activation of the Ca2+-sensitive phosphatase calcineurin (CaN), shifts the phosphorylation status of an unidentified
presynaptic target (T) required for iLTD. The active zone protein RIM1a and the vesicle-associated protein Rab3B are also necessary for iLTD. Induction of eCB-
LTD may require presynaptic Ca2+ rise through VGCCs, NMDARs, or internal stores (not shown). Dashed lines indicate putative pathways.
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lipase (MGL) (Blankman et al., 2007). MGL is found presynapti-
cally (Gulyas et al., 2004; Luda´nyi et al., 2011), but its expression
seems to be heterogeneous across synapses (Tanimura et al.,
2012; Uchigashima et al., 2011; Yoshida et al., 2011). The post-
synaptically localized serine hydrolase ABHD6 also catabolizes
a small fraction of 2-AG (Marrs et al., 2010), suggesting func-
tional redundancy that could help fine-tune 2-AG signaling.
Nevertheless, it seems clear that MGL controls the duration
and magnitude of 2-AG-mediated synaptic plasticity (Hashimo-
todani et al., 2007b; Pan et al., 2011; Schlosburg et al., 2010;
Szabo et al., 2006). While 2-AG probably signals within 20 mm
of its site of origin (Chevaleyre and Castillo, 2004; Wilson and
Nicoll, 2001), it would be useful to examine the relative contribu-
tion of MGL and ABHD6 to 2-AG diffusion.
In contrast to synaptic 2-AG signaling, AEA synthesis and
degradation seems more complex. Postsynaptic depolarization
and intracellular Ca2+ influx support AEA production, but how
this occurs is not fully understood (Di Marzo, 2011). AEA is in
part synthesized by N-acyl-phosphatidylethanolamine-hydro-
lyzing phospholipase-D (NAPE-PLD). However, alternative
synthetic pathways exist (Okamoto et al., 2007). NAPE-PLD
can be expressed postsynaptically (Cristino et al., 2008) but
was also observed on axonal membranes, in particular at CA3
mossy fiber terminals (Egertova´ et al., 2008; Nyilas et al.,
2008), where AEA could locally modulate presynaptic function.
AEA transport across membranes might be facilitated by a lipo-
philic carrier protein (Beltramo et al., 1997; Fu et al., 2012; Hillard
et al., 1997). This protein presumably supports AEA delivery to
intracellular compartments where fatty acid amide hydrolase
(FAAH), the enzyme primarily responsible for AEA degradation,
is localized (Gulyas et al., 2004). While 2-AG and AEA are
hydrolyzed by MGL and FAAH, respectively, oxidizing enzymes
like cyclooxygenase and lipoxygenase can also utilize these72 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.substrates (Vandevoorde and Lambert, 2007). Of interest,
some of these eCB metabolites are biologically active (Nomura
et al., 2011) and probably modulate synaptic function, a possi-
bility that needs to be further investigated. Continued exploration
of the mechanisms underlying eCB synthesis and degradation
will advance our understanding of how lipids shape synaptic
function.
Nonretrograde Endocannabinoid Signaling
Besides the classical cannabinoid receptors (CB1R/CB2R),
there is growing evidence that TRPV1 channels also participate
in eCB signaling (De Petrocellis and Di Marzo, 2010; Pertwee
et al., 2010). TRPV1, originally VR1 for vanilloid receptor type 1
(Caterina et al., 1997), is a polymodal transient receptor potential
(TRP) ion channel largely expressed in afferent peripheral
sensory neurons, where its activation regulates synaptic trans-
mission associated with pain sensation (Caterina and Julius,
2001). Interestingly, TRPV1 can bind lipophilic substances,
such as AEA (Di Marzo et al., 2002). Of note, AEA is a partial
agonist at the CB1R but a full agonist at TRPV1 channels (Smart
et al., 2000; Zygmunt et al., 1999). In addition to their expression
in the periphery, TRPV1 channels have been found in the CNS
(Cristino et al., 2006, 2008; Mezey et al., 2000; Puente et al.,
2011; Roberts et al., 2004; To´th et al., 2005) (but see Cavanaugh
et al., 2011), where they appear to regulate synaptic function.
Recent studies revealed that AEA acting on TRPV1 mediates
a postsynaptic form of LTD (Figure 3A). This TRPV1-LTD has
been observed in dopamine receptor-2 (D2)-positive medium
spiny neurons of the nucleus accumbens (Grueter et al., 2010),
in dentate granule cells (Cha´vez et al., 2010), and in the bed
nucleus of the stria terminalis (Puente et al., 2011). In each
case, activation of mGluR5, presumably via PLC (Liu et al.,
2008) and Ca2+ release from intracellular stores, promotes the
synthesis of AEA that activates TRPV1 channels. In addition,
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Figure 3. Nonretrograde eCB Signaling
(A) Mechanism underlying postsynaptic TRPV1-LTD. Presynaptic activity
releases glutamate that stimulates mGluR5. Postsynaptic depolarization may
also be required. mGluR5 couples to anandamide (AEA) production, which
activates TRPV1, leading to enhanced Ca2+ signaling. Ca2+ engages calci-
neurin/dynamin (CaN/Dyn), causing AMPA receptor (AMPAR) endocytosis and
LTD. IC, intracellular compartment; N. Accumbens, nucleus accumbens;
BNST, bed nucleus of the stria terminalis.
(B) Mechanism responsible for slow self-inhibition (autocrine signaling).
Postsynaptic activity-induced Ca2+ elevation facilitates 2-AG production.
2-AG activates postsynaptic CB1Rs that signal to a G protein-coupled
inwardly rectifying K+ (GIRK) channel to hyperpolarize the membrane potential
and inhibit neuronal firing. Dashed lines indicate putative pathways.
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These findings are consistent with the notion that AEA can act
as an intracellular messenger (van der Stelt and Di Marzo,
2005) but differs from a presynaptic, TRPV1-dependent LTD at
glutamatergic synapses onto CA1 hippocampal interneurons
(Gibson et al., 2008). While CB1Rs mediate excitatory and inhib-
itory synaptic plasticity, whether brain TRPV1 channels mediateinhibitory synaptic plasticity is unknown. There is also evidence
that TRPV1 localizes to neuronal intracellular compartments
like the endoplasmic reticulum, trans-Golgi network, and per-
haps even vesicles (Dong et al., 2010). The functional signifi-
cance of such receptors warrants further investigation.
Nonretrograde eCB signaling has been observed in other
contexts. Repetitive activation of a subtype of neocortical
GABAergic interneuron triggers a CB1R-dependent postsyn-
aptic hyperpolarization, which reduced its excitability (Figure 3B)
(Bacci et al., 2004). This slow self-inhibition resulted from
activity-dependent rises in intracellular Ca2+, mobilization of
2-AG, and activation of CB1Rs that couple to a G protein-
coupled inwardly rectifying K+ channel (Bacci et al., 2004;
Marinelli et al., 2008). This form of autocrine signaling was also
observed in a fraction of layer 2/3 neocortical pyramidal neurons
(Marinelli et al., 2009). Unexpectedly, CB2Rs were recently
shown to mediate an activity-induced self-inhibition in medial
prefrontal cortical pyramidal neurons (den Boon et al., 2012).
CB2Rswere localized to intracellular compartments and coupled
to calcium-activated chloride channels to decrease neuronal
firing. The generalizability of autocrine eCB signaling to other
brain regions should be examined.
Endocannabinoid-Mediated Communication between
Neurons and Glia
Growing evidence indicates that glia participate in eCB signaling
(Stella, 2010). The synthetic machinery for eCB production was
observed in oligodendrocytes (Gomez et al., 2010), astrocytes,
and microglial cells (Hegyi et al., 2012). Likewise, cultured astro-
cytes and microglial cells can produce 2-AG or AEA (Stella,
2009). It is not yet clear whether eCBs produced by glial cells
modulate synaptic transmission. On the other hand, several
recent findings support a role for eCBs signaling to astrocytes
and their ability to indirectly mediate synaptic function.
At Schaffer collateral excitatory synapses onto hippocampal
CA1 pyramidal neurons, postsynaptic activity-dependent
release of eCBs was shown to target not only presynaptic
CB1Rs but also astrocytic CB1Rs (Figure 4A). Astrocytic CB1Rs
unexpectedly coupled to PLC via Gq/11, which increased intra-
cellular Ca2+ and triggered glutamate release (Navarrete and
Araque, 2008). In support of these functional observations,
CB1Rs in hippocampal astrocytes have recently been observed
using immunoelectron microscopy (Han et al., 2012). Glutamate
activated NMDA receptors (NMDARs) on CA1 pyramidal
neurons and, at some synapses, triggered short-term facilitation
of transmitter release, presumably by stimulating presynaptic
mGluR1s (Navarrete and Araque, 2008, 2010). Interestingly,
this short-term facilitation was not spatially restricted, being
observed over 70 mm away from the active pyramidal cell.
Thus, eCBs could concomitantly suppress synaptic transmitter
release by triggering DSE and indirectly potentiate synaptic
transmission through astrocytes, both in a CB1R-dependent
manner. While the functional significance of such plasticity is
not yet clear, astrocytes may have long-distance neuromodula-
tory effects that are mediated by eCB signaling.
eCB-mediated neuron-astrocyte communication has also
been implicated in long-term plasticity. Spike timing-dependent
LTD (tLTD) between neocortical pyramidal neurons is known toNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 73
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Figure 4. Astrocytic CB1R Modulation of Synaptic Transmission
(A) Short-term plasticity. Postsynaptic neuronal activity leads to eCB release.
eCBs target Gq/11-coupled CB1Rs localized to astrocytes. As a result, PLC
activity facilitates astrocytic Ca2+ signaling. Glu released from the astrocyte
activates presynaptic mGluR1s to potentiate release and postsynaptic
NMDARs to trigger a slow inward current.
(B) Spike-timing-dependent LTD. Repetitive pairings of post-before-pre
synaptic activity mobilizes eCBs through the neuronal PLCb-coincidence
detection mechanism. Released eCB stimulates astrocytic CB1Rs, leading to
Ca2+ signaling. Astrocyte-mediated Glu release activates presynaptic
NMDARs to depress release.
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et al., 2006; Nevian and Sakmann, 2006; Sjo¨stro¨m et al., 2003).
Surprisingly, a recent study found that astrocytic CB1Rs were
necessary and sufficient to mediate tLTD (Min and Nevian,
2012). eCBs originating from layer 2/3 pyramidal neurons
activated astrocytic CB1Rs, which increased intracellular
Ca2+, thereby releasing glutamate and stimulating presynaptic
NMDARs (Figure 4B). Given the anatomical and functional
evidence for presynaptic CB1Rs in neocortex (Domenici et al.,
2006; Hill et al., 2007; Lafourcade et al., 2007), future studies
could use astrocyte- and neuron-specific CB1R knockout mice74 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.to identify the exact conditions required to activate neuronal
and/or astrocytic CB1Rs.
Attesting to the possible physiological relevance of astrocytic
CB1Rs, a recent in vivo study showed that intraperitoneal injec-
tion of THC induced long-lasting suppression of excitatory
synaptic transmission in hippocampal area CA1, an effect that
required astrocytic CB1Rs (Han et al., 2012). Previous work in
acute hippocampal slices from global CB1R knockout mice
suggested that agonist-mediated suppression of excitatory
transmission in CA1 depends solely on CB1Rs expressed at
Schaffer collateral terminals (Katona et al., 2006; Kawamura
et al., 2006; Takahashi and Castillo, 2006). Unexpectedly, how-
ever, THC-mediated suppression of synaptic transmission in vivo
was intact in glutamatergic- and GABAergic-specific CB1R
knockout mice, whereas it was abolished in glia-specific CB1R
knockout mice (Han et al., 2012). Mechanistically, glutamate,
presumably released from astrocytes, activated postsynaptic
NMDARs, triggering AMPAR endocytosis and subsequent
synaptic depression. These results contrast with those observed
in vitro in which eCBs indirectly facilitated synaptic transmission
via astrocytic CB1Rs (Navarrete and Araque, 2008, 2010). A
thorough examination of the conditions necessary for activating
synaptic and astrocytic CB1Rs is clearly needed.
Tonic Endocannabinoid Signaling
In addition to the classical, activity-dependent phasic mode of
eCB mobilization, tonic eCB signaling has been reported. Tonic
signaling can be observed as an increase in basal synaptic trans-
mission after pharmacological blockade of CB1Rs (Auclair et al.,
2000; Hentges et al., 2005; Losonczy et al., 2004; Neu et al.,
2007; Oliet et al., 2007; Slanina and Schweitzer, 2005; Zhu and
Lovinger, 2010). However, CB1R blockade in this manner does
not always reveal an eCB tone (Chevaleyre and Castillo, 2003;
Pan et al., 2011; van Beugen et al., 2006; Wilson and Nicoll,
2001; Zhong et al., 2011). Buildup of an eCB tone can occur
when inhibiting eCB uptake (Wilson and Nicoll, 2001) or genetic
deletion of MGL (Pan et al., 2011; Zhong et al., 2011). The fact
that most 2-AG is hydrolyzed by MGL (Blankman et al., 2007;
Chanda et al., 2010; Nomura et al., 2011) suggests that 2-AG
mediates tonic eCBsignaling,which is consistentwith a constitu-
tive release of 2-AG in cultured neurons (Hashimotodani et al.,
2007b). On the other hand, AEA can also contribute to tonic
eCB signaling. Chronic inactivity in hippocampal slice cultures
reduced an AEA tone presumably by augmenting AEA uptake
and degradation (Kim and Alger, 2010). Together, these studies
suggest that tonic eCB signaling can control, under some condi-
tions, basal synaptic neurotransmitter release. It is currently
unclear whether regional differences in the expression pattern
of enzymes responsible for eCB metabolism can fully account
for synapse specificity. Moreover, most of these studies were
performed in vitro, and therefore the impact of an eCB tone on
synaptic function in vivo should be further examined.
Interaction between Endocannabinoids and Other
Signaling Systems
The eCB system allows for multiple points of interaction with
other signaling and neuromodulatory systems. In addition to
regulating release of classical neurotransmitters like glutamate
Neuron
Reviewand GABA, CB1Rs can also control the release of several
neuromodulators including serotonin, acetylcholine, dopamine,
opioids, norepinephrine, and cholecystokinin (Alger, 2002;
Kano et al., 2009; Schlicker and Kathmann, 2001). On the other
hand, many of these neuromodulators actually couple to eCB
synthesis by activating their respective Gq/11 protein-coupled
receptors (for a comprehensive list, see Katona and Freund,
2012). Additionally, regulators of G protein signaling were
recently shown to control Gq/11-coupled receptors and eCB
mobilization (Lerner and Kreitzer, 2012), indicating how GPCRs
themselves can fine-tune eCB release. Together, these studies
not only support a general theme by which Gq/11-coupled
GPCRsmobilize eCBs but demonstrate the existence of multiple
routes for eliciting and regulating eCB release.
On the other side of the synapse, functional interactions
between CB1Rs and other receptors have been identified. For
example, at inhibitory terminals in the prefrontal cortex, D2-like
receptors colocalize with CB1Rs where they appear to facilitate
CB1R-mediated suppression of transmitter release (Chiu et al.,
2010). This is probably due to a cooperative lowering of PKA
activity, consistent with similar observations in the ventral
tegmental area (Pan et al., 2008). In addition, work in visual
cortical slices from young mice suggests that BDNF interferes
with CB1R downstream signaling, thereby disrupting eCB-medi-
ated suppression of neurotransmitter release (Huang et al.,
2008). This might result from, at least in part, BDNF inhibiting
CB1R function through a mechanism requiring cholesterol
metabolism and altered membrane lipid raft function (De Chiara
et al., 2010). At Schaffer collaterals, adenosine A1 receptors
(A1Rs) colocalize with CB1Rs. Tonic activation of A1Rs can
reduce the efficacy of CB1R-mediated inhibition of glutamate
release (Hoffman et al., 2010). Also in the hippocampus, stimu-
lating GluK1-containing kainate receptors at inhibitory terminals
appears to actually facilitate CB1R signaling (Lourenc¸o et al.,
2010). Themechanism by which this occurs is not yet clear. Add-
ing to the complexity of eCB signaling, evidence suggests that
CB1Rs can associate with other GPCRs to form heteromeric
complexes. Such interactions have been detected for CB1-D2,
CB1-opioid, CB1-A2A, and CB1-orexin-1 receptor pairs (Hudson
et al., 2010; Mackie, 2005; Pertwee et al., 2010). Strikingly,
higher-order heteromeric complexes consisting of CB1, D2,
and A2ARs have also been observed (Carriba et al., 2008).
Intriguingly, these macromolecular interactions can significantly
change the downstream G proteins recruited during receptor
activation. Much more work is needed to determine the physio-
logical impact of these heteromeric complexes in the brain and,
in particular, at the synapse.
Plasticity of the Endocannabinoid System
In addition to triggering various forms of synaptic plasticity like
DSI/DSE, eCB-LTD, and TRPV1-LTD, the eCB system itself
undergoes plastic changes. Mechanistically, plasticity of the
eCB system can arise bymodifications to any of its components,
for example, CB1R number and function or eCB production and
degradation. These changes have been observed both in vivo
and in vitro and can be triggered by several natural and experi-
mental conditions including neural activity and agonist-induced
CB1R activation. Of clinical relevance, changes in eCB signalingare also associated with several brain disorders. Here, we
illustrate how plasticity of the eCB system can profoundly affect
synaptic physiology and, ultimately, brain function.
An interesting example of agonist-induced plasticity of eCB
signaling comes from the observation that a single in vivo expo-
sure to THC abolished for a few days eCB-mediated retrograde
signaling in the hippocampus and nucleus accumbens of mice
(Mato et al., 2004). This effect was associated with a reduction
in CB1R maximal efficacy without modifications in total binding
or coupling. Prolonged exposure to agonists in humans and
animal models results in behavioral tolerance, which is classi-
cally attributed to receptor desensitization and internalization
(Coutts et al., 2001; Jin et al., 1999; Wu et al., 2008). However,
a reduction in CB1R lateral mobility may also contribute (Mika-
sova et al., 2008). Understanding the impact of synaptic CB1R
signaling and trafficking in vivo should further reveal how eCBs
control physiological responses to drugs of abuse.
The eCB system also undergoes developmental changes
(Harkany et al., 2008). In the hippocampus, both the magnitude
of eCB-mediated iLTD and the ability of a CB1R agonist to
suppress inhibitory transmission were greater in juvenile than
in adult rats (Kang-Park et al., 2007; see also Zhu and Lovinger,
2010). In addition, a form of eCB-mediated heterosynaptic LTD
at excitatory synapses was observed in young animals, attenu-
ated across development, and disappeared in the mature brain
(Yasuda et al., 2008). Lower expression levels of CB1Rs at excit-
atory synapses in the adult brain may underlie these changes
(Kawamura et al., 2006). Along these lines, developmentally
expressed CB1Rs at mossy fiber terminals in the CA3 region of
the hippocampus mediate eCB-LTD at immature but not mature
synapses (Caiati et al., 2012). Postsynaptic eCB production is
also modulated over time. A developmental shift from long-
term potentiation (LTP) to eCB-LTD was reported in the striatum
(Ade and Lovinger, 2007). Whereas CB1R sensitivity to its
agonist was not changed, the shift in plasticity was associated
with developmental increases in AEA levels, suggesting that
AEA determines the direction of synaptic plasticity. Similarly, it
was shown that the magnitude of hippocampal DSI is develop-
mentally regulated, such that DSI is modest in early postnatal
days and becomes more robust at 2 weeks postnatal (Zhu and
Lovinger, 2010). The mechanism is not entirely clear but it might
rely on a postsynaptic change in eCB release. In addition, tonic
eCB release suppresses GABAergic transmission in the mature
but not the neonatal hippocampus (Kang-Park et al., 2007; Zhu
and Lovinger, 2010). While these studies argue that synaptic
eCB signaling is developmentally regulated, the exact mecha-
nisms underlying these changes remain unclear.
In mature animals, eCB signaling can be modified in an
activity-dependent manner. High-frequency (Chen et al., 2007)
or low-frequency (Zhu and Lovinger, 2007) stimulation of
Schaffer collaterals, as well as brief pharmacological activation
of I mGluRs (Edwards et al., 2008), triggered a long-lasting
potentiation in the magnitude of DSI. Remarkably, the transient
postsynaptic Ca2+ rise that occurs during a single episode of
DSI facilitated subsequent I mGluR-dependent mobilization of
eCBs and the induction of iLTD (Edwards et al., 2008). The
molecular components that undergo priming are unknown. A
similar DSI potentiation was observed after a single episode ofNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 75
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potentiation was due to an increase in the number of CB1Rs
associated with perisomatic inhibitory inputs. In contrast, the
epileptic human hippocampus showed a reduction in the
expression of CB1Rs at glutamatergic terminals (Luda´nyi et al.,
2008). Nevertheless, both upregulation of CB1Rs at GABAergic
terminals and downregulation of CB1Rs at excitatory terminals
are potentially epileptogenic, suggesting that dysregulation of
the eCB system could play a role in epilepsy. Identifying the
molecular basis for these activity-dependent changes in CB1R
expression levels is important because it may uncover novel
therapeutic targets.
Altered eCB signaling has been reported in experimental
models for disorders like fragile X syndrome. Upregulation of
eCB signaling was found in fragile X mental retardation protein
knockout mice as indicated by facilitation of I mGluR agonist-
induced iLTD. Facilitated iLTD might result from aberrant
coupling between I mGluR activation and eCB mobilization
(Zhang and Alger, 2010). Aberrant coupling might be due to
changes in Homer 1a protein, which reportedly interacts with
mGluRs to regulate eCB release in cultured hippocampal
neurons (Roloff et al., 2010). Another possible mediator of
aberrant coupling includes the excitatory synapse-specific
scaffolding protein SAPAP3, which can modulate postsynaptic
mGluRs and eCB-mediated synaptic plasticity in the striatum
(Chen et al., 2011). Continued exploration of the mechanisms
underlying mGluR-coupled eCB production should provide
clues as to how to treat patients with fragile X syndrome.
Several studies indicate that physiological responses to stress
modulate the expression levels of key components of the eCB
system (Riebe and Wotjak, 2011). In general, how stress modu-
lates eCB signaling is largely dependent on brain regions, stress
paradigm, and duration of stress exposure. In the striatum and
nucleus accumbens, chronic stress inhibited CB1R-mediated
suppression of synaptic transmission (Rossi et al., 2008; Wang
et al., 2010). Downregulation of CB1R function might underlie
this eCB signaling deficiency since stress-induced downregula-
tion of CB1R function was observed in the hypothalamus (Wam-
steeker et al., 2010). There is also evidence that stress can
enhance eCB signaling. Repeated restraint stress increased
2-AG levels and enhanced DSI in the basolateral amygdala (Patel
et al., 2009). Similarly, restraint stress increased 2-AG levels and
enhanced DSI in hippocampal CA1 pyramidal neurons (Wang
et al., 2012).
Food intake is another physiological process that modulates
the eCB system (Banni and Di Marzo, 2010; DiPatrizio and
Piomelli, 2012). For example, CB1R agonists increase food
intake, whereas antagonists reduce food consumption.
Providing mechanistic insight as to how this modulation may
occur, a recent study showed that diet-induced obesity in mice
increased hippocampal DGLa protein, 2-AG and AEA produc-
tion, as well as CB1R expression (Massa et al., 2010). Levels of
DGLb, MGL, and FAAH were unchanged. Consistently, DSI
and eCB-mediated iLTD were augmented in these mice (Massa
et al., 2010). Diet restrictions likewise cause significant changes
in the eCB system. In hypothalamic feeding circuits, food
deprivation downregulated CB1R signaling, converting eCB-
mediated LTD-expressing synapses into ones that show76 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.nitric-oxide-dependent LTP (Crosby et al., 2011). In addition,
polyunsaturated fatty acid diet-deficient mice showed impaired
eCB-mediated LTD in both prefrontal cortex and nucleus
accumbens (Lafourcade et al., 2011). Lack of eCB-LTD was
attributed to reduced coupling of the CB1R to its downstream
Gi/o protein. Intriguingly, these mice exhibited defects in mood
and emotional behavior, implicating synaptic eCB signaling in
affective behaviors. Taken together, these studies highlight
how behavioral manipulations profoundly regulate eCB signaling
and synaptic function.
Conclusions and Future Directions
In this Review, we have highlighted essential properties of eCB
signaling at the synapse. Research in the last decade has
bolstered eCBs as powerful regulators of synaptic function
throughout the CNS. Exciting developments have uncovered
new mechanisms underlying eCB-mediated regulation of
synaptic transmission. Moreover, the dynamics of synaptic
eCB signaling display an intricate, and sometimes reciprocal,
set of interactions with other neuromodulatory systems. These
emerging levels of complexity clearly indicate that much more
work lies ahead in our pursuit to fully understand eCB signaling
at the synapse.
While an overwhelming body of evidence strongly suggests
that eCBs are retrograde synaptic messengers, a major out-
standing issuewith themodel is how a lipid traverses an aqueous
synaptic cleft. Furthermore, once produced, how far do eCBs
diffuse? While AEA seems to be transported by a lipid carrier
protein, whether 2-AG is also transported by a lipid chaperone
is unknown. Alternatively, specialized protein/lipid bridges, akin
to synaptic intercellular adhesionmolecules, could adopt a struc-
tural conformation that exposes lipophilic patches to reduce the
retrograde energy barrier. Regardless of the exact mechanism, it
is clear that eCB signaling powerfully regulates synaptic func-
tion. Developing new technologies to image lipid signaling, in
real time, should dramatically propel the field of eCB research
forward.
Apart from their more traditional role in retrograde signaling,
eCBs also appear to act in a nonretrograde manner to modulate
postsynaptic function as well as trigger gliotransmission. How-
ever, the general physiological relevance of nonretrograde
signaling mediated by TRPV1 in the CNS is not yet clear. While
experimental evidence for eCBs targeting postsynaptic recep-
tors is growing, whether presynaptically produced eCBs activate
presynaptic CB1Rs or TRPV1 channels to modulate synaptic
function remains unknown. In addition, the role of CB1Rs in
regulating gliotransmission and, indirectly, synaptic plasticity
warrants further investigation. Given themyriad of evidence sup-
porting synaptic CB1Rs in modulating synaptic transmission, the
precise conditions necessary for activating neuronal versus
astrocytic CB1Rs must be defined.
Several other fundamental mechanistic questions remain un-
answered. What are the rules governing CB1R trafficking into
and out of membranes? What are the conditions required for
CB1R heteromerization with other neuromodulatory receptors,
and what is their impact on synaptic function? As for the two
main eCBs, 2-AG and AEA, are there specific patterns of activity
that predominantly mobilize one lipid versus the other? Perhaps
Neuron
Reviewthese eCBs subserve specific functions at the synapse. If so,
which ones? What is the precise role of tonic eCB release in
the brain? In vitro approaches are unquestionably useful for
addressing fundamental mechanisms underlying synaptic eCB
signaling, but much more work in vivo is required to determine
their contribution to physiological and pathological conditions.
While a great deal of progress has been made in our under-
standing of eCB signaling and synaptic function, the greatest
challenges lie ahead.ACKNOWLEDGMENTS
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